Skip to content
10-Q

Quarterly Report

QUANTRX BIOMEDICAL CORPORATION

0001654954-20-009140

← back to feed
Filed
Aug 14, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Aug 14, 2020 78.7M sh
Current Liabilities Q2 2020 · Jun 30, 2020 $2.34M
Current Liabilities Q2 2020 · Dec 31, 2019 $2.27M
Total Liabilities Q2 2020 · Jun 30, 2020 $2.34M
Total Liabilities Q2 2020 · Dec 31, 2019 $2.27M
Current Assets Q2 2020 · Jun 30, 2020 $83.41K
Current Assets Q2 2020 · Dec 31, 2019 $137.35K
Total Assets Q2 2020 · Jun 30, 2020 $83.41K
Total Assets Q2 2020 · Dec 31, 2019 $137.35K
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$120.89K
Cash And Equivalents Q2 2020 · Jun 30, 2019 $201.14K
Cash And Equivalents Q2 2020 · Dec 31, 2018 $322.02K
Stockholders Equity Q2 2020 · Jun 30, 2019 −$1.72M
Stockholders Equity Q2 2020 · Mar 31, 2019 −$1.62M
Stockholders Equity Q2 2020 · Dec 31, 2018 −$1.51M
Sga Expense Q2 2020 · Jun 30, 2019 $16.78K
Sga Expense Q2 2020 · Jun 30, 2019 $39.36K
Net Income Q2 2020 · Jun 30, 2019 −$97.48K
Net Income Q2 2020 · Jun 30, 2019 −$209.69K
Operating Income Q2 2020 · Jun 30, 2019 −$61.84K
Operating Income Q2 2020 · Jun 30, 2019 −$120.84K